Data gathered: May 29
AI Stock Analysis - Charles River Laboratories (CRL)
Analysis generated August 19, 2024. Powered by Chat GPT.
Charles River Laboratories International, Inc. (NYSE: CRL) is a global provider of essential products and services to expedite the discovery, early-stage development, and safe manufacture of novel drugs and therapeutics. They operate through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (MS). With an extensive portfolio of services, Charles River Laboratories aims to enhance the productivity and efficiency of pharmaceutical and biotechnology companies, government agencies, and leading academic institutions worldwide.
Stock Alerts - Charles River Laboratories (CRL)
 |
Charles River Laboratories | May 21 AI Score is down by 21.4% in the last couple of days. |
|
Charles River Laboratories | May 20 Employee Rating is up by 3.2% over the last month. |
|
Charles River Laboratories | May 16 Insider Alert: MASSARO GEORGE is selling shares |
|
Charles River Laboratories | May 10 Rob Bresnahan (member of U.S. congress) is buying shares |
Download our app to get future alerts delivered in real-time.
Alternative Data for Charles River Laboratories
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 547 | Sign up | Sign up | Sign up |
| Sentiment | 90 | Sign up | Sign up | Sign up |
| Webpage traffic | 202,000 | Sign up | Sign up | Sign up |
| Employee Rating | 62 | Sign up | Sign up | Sign up |
| Google Trends | 44 | Sign up | Sign up | Sign up |
| Patents | 6 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 204 | Sign up | Sign up | Sign up |
| Facebook Followers | 22,190 | Sign up | Sign up | Sign up |
| Instagram Followers | 5,317 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 2 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 906 | Sign up | Sign up | Sign up |
| Twitter Followers | 9,165 | Sign up | Sign up | Sign up |
| Twitter Mentions | N/A | Sign up | Sign up | Sign up |
| Youtube Subscribers | 4,220 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 27 | Sign up | Sign up | Sign up |
| Linkedin Employees | 14,582 | Sign up | Sign up | Sign up |
About Charles River Laboratories
Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions. It operates through the following segments: Research Models & Services, Discovery & Safety Assessment and Manufacturing Support.
| Price | $136.25 |
| Target Price | Sign up |
| Volume | 600,730 |
| Market Cap | $6.81B |
| Year Range | $99.75 - $220.69 |
| Dividend Yield | 0% |
| PE Ratio | 592.3 |
| Analyst Rating | 7% buy |
| Industry | Biotechnology |
In the news
Charles River Laboratories International Extend Drug Discovery Partnership With CHDI FoundationMay 27 - Finnhub |
|
 |
Do Wall Street Analysts Like Charles River Laboratories Stock?May 27 - Biztoc.com |
 |
Charles River Laboratories International (NYSE:CRL) Upgraded at Redburn AtlanticMay 24 - ETF Daily News |
|
Nuveen Asset Management LLC Has $23.46 Million Stake in Charles River Laboratories International, Inc. (NYSE:CRL)May 24 - ETF Daily News |
Redburn Upgrades Charles River Laboratories (CRL) to Buy, Cuts PTMay 24 - Yahoo Entertainment |
|
Redburn Atlantic Upgrades Charles River Laboratories International (CRL)May 23 - Fintel |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 984M | 666M | 318M | 25M | 184M | 2.340 |
| Q4 '24 | 1B | 718M | 278M | -216M | -86M | 2.660 |
| Q3 '24 | 1.01B | 661M | 349M | 69M | 210M | 2.590 |
| Q2 '24 | 1.03B | 691M | 335M | 90M | 239M | 2.800 |
| Q1 '24 | 1.01B | 691M | 320M | 67M | 219M | 2.270 |
Insider Transactions View All
| MASSARO GEORGE filed to sell 5,575 shares at $139.1. May 16 '25 |
| MASSARO GEORGE filed to sell 5,680 shares at $136.3. May 16 '25 |
| MASSARO GEORGE filed to sell 5,599 shares at $137.7. May 16 '25 |
| MASSARO GEORGE filed to sell 5,715 shares at $145.5. May 15 '25 |
| MASSARO GEORGE filed to sell 5,729 shares at $141.9. May 15 '25 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Rob Bresnahan |
May 8, 25 | Buy | $15K - $50K |
| Julie Johnson |
Feb 13, 25 | Buy | $1K - $15K |
| Ro Khanna |
Dec 6, 24 | Buy | $1K - $15K |
Read more about Charles River Laboratories (CRL) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Charles River Laboratories?
The Market Cap of Charles River Laboratories is $6.81B.
What is Charles River Laboratories' PE Ratio?
As of today, Charles River Laboratories' PE (Price to Earnings) ratio is 592.3.
What is the current stock price of Charles River Laboratories?
Currently, the price of one share of Charles River Laboratories stock is $136.25.
How can I analyze the CRL stock price chart for investment decisions?
The CRL stock price chart above provides a comprehensive visual representation of Charles River Laboratories' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Charles River Laboratories shares. Our platform offers an up-to-date CRL stock price chart, along with technical data analysis and alternative data insights.
Does CRL offer dividends to its shareholders?
As of our latest update, Charles River Laboratories (CRL) does not offer dividends to its shareholders. Investors interested in Charles River Laboratories should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Charles River Laboratories?
Some of the similar stocks of Charles River Laboratories are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.